FDA Inspection 1055499 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA completed an inspection of IPR Pharmaceuticals, Inc. on June 14, 2018 in Canovanas, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)

Citations

IDCFRDescription
358521 CFR 211.110(a)Control procedures to monitor and validate performance